Company Filing History:
Years Active: 1996-2000
Title: **Neil A Munday: Innovator in Genetic Engineering**
Introduction
Neil A Munday, a distinguished inventor located in Guelph, Canada, has made notable contributions in the field of genetic engineering. With a total of four patents to his name, Munday has demonstrated a keen ability to innovate and address important challenges in biotechnology.
Latest Patents
Among his latest achievements is the patent related to DNA encoding the precursor of interleukin-1 beta-converting enzyme. This patent details a complementary DNA (cDNA) that encodes the full-length form of ICE-related protein II. This groundbreaking work identifies, sequences, and isolates the cDNA, which is subsequently cloned into expression vectors for expression in recombinant hosts. The innovative cDNA is particularly valuable for producing recombinant full-length ICE-related protein II, which can have significant applications in diagnostic kits, laboratory reagents, and assays. Furthermore, this cDNA and the resultant recombinant protein can assist in identifying compounds that influence ICE-related protein II function, inflammation, and cell apoptosis, highlighting the potential for advancements in gene therapy and antisense technology.
Career Highlights
Throughout his distinguished career, Neil A Munday has held significant roles at notable organizations, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His work in these companies has contributed to his extensive expertise in the biotechnology sector, particularly in relation to interleukin-1 beta-related research.
Collaborations
Munday has collaborated with respected colleagues, including Donald W Nicholson and Ambereen Ali. These collaborations reflect his commitment to advancing research in the field and working alongside other innovators to enhance scientific understanding and technological development.
Conclusion
Neil A Munday’s contributions to genetic engineering showcase his innovative spirit and dedication to addressing medical challenges through scientific research. His patents play a vital role in enhancing the understanding of inflammatory processes and apoptosis, paving the way for future discoveries and applications in biotechnology.